BLOG
FDA – OA REMS Announcement Concerning requirements to Manufacturers of Opioids
New FDA - OA REMS Announcement Written-by: Deneen Fumich, RPh April 21, 2022, FDA published in the Federal Register open comments under the Support Act which authorized FDA to require through a Risk Evaluation and Mitigation Strategy (REMS) that a safe disposal...
Recent Articles
What is the Big Deal about Quantitative Thresholds?
What is the Big Deal about Quantitative Thresholds? Written-by: Deneen Fumich, RPh Since July 21, 2021, industry has been hearing, reading and...
National Drug Shortages: Can Compounding Pharmacies Assist?
Can Compounding Pharmacies Help With Drug Shortage? Written-by: Deneen Fumich, RPh As parents, grandparents and caregivers, we all can relate to the...
New DEA Guidance On Quantitative Thresholds
Guidance On Quantitative Thresholds Written-by: Deneen Fumich, RPh As the Pharmaceutical Supply Chain continues to digest the Injunctive Relief...
Oklahoma Prescription Shipping Proposed Rules
Oklahoma Prescription Shipping Proposed Rules Written-by: Deneen Fumich, RPh Controlled Temperature of Prescription Drugs Shipped to Residents of...
2022 Letter From The CEO
2022 Letter From The CEO Written-by: Sumeet Singh, Chief Executive Officer As we near 2023, I want to reflect on this past year and the massive...
Manufacturers, Are You Complying with State Required Drug Takeback Programs?
Manufacturers, Are You Complying with State Required Drug Takeback Programs? Written-by: Deneen Fumich, RPh Did you know that as a manufacturer,...
